Correction: Wang et al. Exploration of the Inhibitory Potential of Varespladib for Snakebite Envenomation. <i>Molecules</i> 2018, <i>23</i>, 391
The authors would like to correct an error in the original publication [...]
Main Authors: | Yiding Wang, Jing Zhang, Denghong Zhang, Huixiang Xiao, Shengwei Xiong, Chunhong Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-08-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/27/16/5269 |
Similar Items
-
Exploration of the Inhibitory Potential of Varespladib for Snakebite Envenomation
by: Yiding Wang, et al.
Published: (2018-02-01) -
The BRAVO Clinical Study Protocol: Oral Varespladib for Inhibition of Secretory Phospholipase A2 in the Treatment of Snakebite Envenoming
by: Rebecca W. Carter, et al.
Published: (2022-12-01) -
Varespladib in the Treatment of Snakebite Envenoming: Development History and Preclinical Evidence Supporting Advancement to Clinical Trials in Patients Bitten by Venomous Snakes
by: Matthew R. Lewin, et al.
Published: (2022-11-01) -
A First Look at the Inhibitory Potential of <i>Urospatha sagittifolia</i> (Araceae) Ethanolic Extract for <i>Bothrops atrox</i> Snakebite Envenomation
by: Antonio L. Vera-Palacios, et al.
Published: (2022-07-01) -
Snakebite envenoming
by: Gutiérrez, J, et al.
Published: (2017)